| __timestamp | Amneal Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 5903000 |
| Thursday, January 1, 2015 | 367054000 | 2762000 |
| Friday, January 1, 2016 | 420770000 | 1114000 |
| Sunday, January 1, 2017 | 507476000 | 25573000 |
| Monday, January 1, 2018 | 946588000 | 6000000 |
| Tuesday, January 1, 2019 | 1273376000 | 38845000 |
| Wednesday, January 1, 2020 | 1364130000 | 50523000 |
| Friday, January 1, 2021 | 1324696000 | 75463000 |
| Saturday, January 1, 2022 | 1427596000 | 105767000 |
| Sunday, January 1, 2023 | 1573042000 | 167512000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. present a fascinating case study in contrasting cost of revenue trends from 2014 to 2023. Amneal's cost of revenue surged by approximately 368%, starting from a modest 336 million in 2014 to a staggering 1.57 billion by 2023. This growth reflects their aggressive expansion and scaling strategies. In contrast, Xenon Pharmaceuticals, Inc. experienced a more modest increase of around 2,736%, from just over 1 million in 2016 to 168 million in 2023. This dramatic rise, albeit from a smaller base, highlights Xenon's strategic pivot towards innovative drug development. These trends underscore the diverse strategies employed by pharmaceutical companies to navigate market challenges and opportunities over the past decade.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Xenon Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: AbbVie Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Amneal Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Insmed Incorporated and Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Cytokinetics, Incorporated vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Xenon Pharmaceuticals Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Xenon Pharmaceuticals Inc. vs MiMedx Group, Inc.